ANGPTL3 and hypertriglyceridemia: After considering these reports, and in light of our previous finding that insulin can stimulate secretion of ANGPTL3/8 from hepatocytes (11), we hypothesized that LXR agonists might cause hypertriglyceridemia by stimulating hepatic secretion of ANGPTL3/8.